Synta Pharmaceuticals Corp (NASDAQ:SNTA)

Delayed Data
As of Jul 02
 -0.02 / -0.91%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 6.50, with a high estimate of 13.00 and a low estimate of 1.00. The median estimate represents a +198.17% increase from the last price of 2.18.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.38%
Growthannually 15.52%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account